Laboratory aspects of intermittent drug therapy.
D000818:Animals; D005000:Ethionamide / Q000627:therapeutic use; D006128:Growth / Q000187:drug effects; D006168:Guinea Pigs; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000097:blood; D012293:Rifampin / Q000008:administration & dosage*; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*
D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin